Palomar Medical Technologies (NASDAQ: PMTI) is one of 81 public companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it weigh in compared to its competitors? We will compare Palomar Medical Technologies to similar companies based on the strength of its institutional ownership, profitability, earnings, risk, analyst recommendations, valuation and dividends.
Earnings and Valuation
This table compares Palomar Medical Technologies and its competitors top-line revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Palomar Medical Technologies||N/A||N/A||-49.67|
|Palomar Medical Technologies Competitors||$975.11 million||$120.37 million||260.08|
Risk and Volatility
Palomar Medical Technologies has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Comparatively, Palomar Medical Technologies’ competitors have a beta of 0.92, suggesting that their average share price is 8% less volatile than the S&P 500.
This is a breakdown of current ratings for Palomar Medical Technologies and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Palomar Medical Technologies||0||0||0||0||N/A|
|Palomar Medical Technologies Competitors||219||1275||2752||97||2.63|
As a group, “Medical Equipment, Supplies & Distribution” companies have a potential upside of 6.22%. Given Palomar Medical Technologies’ competitors higher probable upside, analysts clearly believe Palomar Medical Technologies has less favorable growth aspects than its competitors.
Insider and Institutional Ownership
65.5% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 12.0% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
This table compares Palomar Medical Technologies and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Palomar Medical Technologies||N/A||N/A||N/A|
|Palomar Medical Technologies Competitors||-420.92%||-42.44%||-12.14%|
About Palomar Medical Technologies
Palomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.
Receive News & Ratings for Palomar Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.